Therapeutic Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Neuroinflammation and Neuroplasticity in Patients with Parkinson’s Disease: a Placebo-Controlled Study

L. I. Aftanas, M. M. Gevorgyan, S. Y. Zhanaeva, S. S. Dzemidovich, K. I. Kulikova, E. L. Al’perina, K. V. Danilenko, G. V. Idova

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

The parallel placebo-controlled study examined the therapeutic effects of dual-target repetitive transcranial magnetic stimulation (rTMS) of the motor cortex (bilaterally) and the left prefrontal cortex (dorsolaterally) on spontaneous and mitogen-stimulating synthesis of pro- and anti-inflammatory cytokines by the blood cells and the level of brain-derived neurotrophic factor (BDNF) in blood serum of patients with Parkinson’s disease. The significantly steeper positive clinical dynamics (assessed by UPRSD scale) observed in rTMS group in comparison with the placebo group was accompanied by a significant drop in spontaneous production of proinflammatory cytokines IFNγ and IL-17A. rTMS produced no significant effect on serum BDNF. The possible mechanisms of rTMS therapeutic action on the level of cytokines associated with neuroinflammation in patients with Parkinson’s disease are discussed.

Original languageEnglish
Pages (from-to)195-199
Number of pages5
JournalBulletin of Experimental Biology and Medicine
Volume165
Issue number2
DOIs
Publication statusPublished - Jun 2018

Keywords

  • BDNF
  • Parkinson’s disease
  • high-frequency repetitive transcranial magnetic stimulation (rTMS)
  • pro- and anti-inflammatory cytokines
  • Parkinson's disease
  • RAT
  • MOTOR
  • DOPAMINE
  • MECHANISMS

Fingerprint Dive into the research topics of 'Therapeutic Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Neuroinflammation and Neuroplasticity in Patients with Parkinson’s Disease: a Placebo-Controlled Study'. Together they form a unique fingerprint.

Cite this